About the Conference

The medical technology industry is witnessing a growing number of mergers and acquisitions, and poses a unique set of challenges when it comes to due diligence. Regulatory, quality, and compliance experts are drawn from their regular tasks and asked to validate statements and assumptions, evaluate the findings, and map strategies for integration. What should you look for in terms of submissions and regulatory status, quality systems, clinical studies and evidence, and compliance? What are the typical hidden landmines that can make a financially promising deal turn sour? What post-acquisition planning should take place for integration or harmonization of the two entities and remediation of any problems

This interactive conference, mixing didactic sessions with discussion and case studies, is led by senior industry professionals who have gone through mergers and acquisitions and seen both the good and the bad, focuses on those issues unique to medical technology companies.

Topics will include:

  • The M&A process
  • Issues unique to med tech M&A
  • Quality due diligence
  • Regulatory due diligence
  • Clinical / medical due diligence
  • Effective presentation of quality and regulatory findings to senior management
  • Discussions with regulatory around M&A
  • Budgeting and planning for post-acquisition activities
  • Integration, harmonization, and remediation
  • Common issues and hidden deal-breaking problems
  • Case studies

Who should attend:

  • Senior management of acquiring / merging companies
  • Senior management of companies wishing to be acquired
  • Senior regulatory professionals
  • Senior quality professionals
  • Senior clinical medical professionals involved in trials and evidence development
  • Compliance officers
  • Legal counsel


  • Tony Blank - Co-Founder & Senior Advisor, Barton & Blank
  • Mark Gordon - Sr. Vice-President, Global Head, Regulatory Affairs, Alcon
  • Mike Heyl - Partner, Hogan Lovells
  • Karen Mahoney - WW Senior Director, Regulatory Affairs, DePuy
  • Judith O'Grady - Corporate VP, Global Regulatory Affairs & Corporate Compliance Officer, Integra Life Sciences
  • Patricia Shrader - Of Counsel, Hogan Lovells

CEU Information

Attendees can earn CEUs. 1 hour of the conference = 1 CEU. MedTech Intelligence will provide you a Certificate of Attendance with the amount of CEU's earned about three weeks after the conference.

MTI's conference CEUs can be applied to your Regulatory Affairs Certification.

  • When

  • Wednesday, October 23, 2019 - Thursday, October 24, 2019
    11:00 AM - 4:00 PM

  • Where

  • Virtual Event

Outlook Outlook
iCal iCal
Google Google
Yahoo! Yahoo!